Rare Diseases (Rare Disease) Summary

Networked: 2221 relevant articles (46 outcomes, 89 trials/studies) for this Disease

Key Drugs and Agents for Rare Diseases

1. Immunoglobulins (Immunoglobulin) : 2 outcomes 1 study in 14 results : IBA
   
2. Vaccines : 2 outcomes in 5 results : IBA
   
3. Biological Markers (Surrogate Marker) : 1 outcome 10 studies in 22 results : IBA
   
4. Idiopathic pulmonary hypertension : 1 outcome 2 studies in 101 results : IBA
   
5. Plastics : 1 outcome 2 studies in 15 results : IBA
   
6. Complement System Proteins (Complement) : 1 outcome 1 study in 16 results : IBA
   
7. imatinib (Gleevec) : 1 outcome 1 study in 6 results : FDA 3
   
8. Oxygen : 1 outcome 1 study in 3 results : IBA
   
9. N- (4- bromo- 2- fluorophenyl)- 6- methoxy- 7- ((1- methylpiperidin- 4- yl)methoxy)quinazolin- 4- amine (ZD6474) : 1 outcome 1 study in 3 results : IBA
   
10. rituximab (Mabthera) : 1 outcome 1 study in 3 results : FDA 3
    

Diseases Related to Rare Diseases

1. Vasculitis (Vasculitides)
2. Neoplasms (Cancer)
3. Bronchitis
4. Infection
5. Large Granular Lymphocytic Leukemia

Key Therapies for Rare Diseases

1. Therapeutics : 4 outcomes 4 studies in 22 results
   
2. Drug Therapy (Chemotherapy) : 3 outcomes 3 studies in 50 results
   
3. Transplantation (Transplant Recipients) : 1 outcome 1 study in 19 results
   
4. Radiotherapy : 1 outcome 1 study in 18 results
   
5. Drug Repositioning : 1 outcome 1 study in 2 results